3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioma
1
Interventions
pembrolizumab
32
Carboplatin
17
Nivolumab
14
Cisplatin
14
atezolizumab
11
Pemetrexed
11
Paclitaxel
11
Ipilimumab
11
venetoclax
10
Radiotherapy
10
durvalumab
9
Gemcitabine
9
Docetaxel
9
fludarabine
8
Cyclophosphamide
8
Specimen Handling
7
Biopsy
7
Bevacizumab
7
tislelizumab
6
fludarabine phosphate
6
enzalutamide
6
Trastuzumab
6
Practice Guidelines as Topic
6
Cetuximab
6
tazemetostat
5
Surveys and Questionnaires
5
Standard of Care
5
Radiosurgery
5
Magnetic Resonance Spectroscopy
5
Injections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Diphtheria-Tetanus Vaccine
×
90 days
×
Clear all
NCT03334305
2026-04-23
ACTION
University of Florida
Phase 1
Terminated
18 enrolled
11 charts